Achieve Life Sciences market cap ACHV
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Nov 2, 2026
- $680.2M
- Highest close in our data
- $873.6M
- Sep 2026
Achieve Life Sciences is worth $680.2M at the close on Nov 2, 2026, at $6.61 a share.
That is up 178% over the last year and up 735% over five years.
Its highest close in our data was $873.6M in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $680.2M | $141.1M | $873.6M | +185% |
| 2025 | $239M | $69M | $261.7M | +91% |
| 2024 | $125.2M | $82.1M | $185.8M | +44% |
| 2023 | $87.2M | $25.3M | $156.2M | +267% |
| 2022 | $23.8M | $19.6M | $79.1M | −68% |
| 2021 | $73.5M | $31.9M | $88.6M | +151% |
| 2020 | $29.3M | $3.9M | $39.4M | +550% |
| 2019 | $4.5M | $4M | $29.2M | −44% |
| 2018 | $8.1M | $4.1M | $21.3M | −50% |
| 2017 | $16M | $4.4M | $21M | +7% |
| 2016 | $15M | $11.7M | $35.9M | −58% |
| 2015 | $36.1M | $34.9M | $87.9M | −23% |
| 2014 | $46.8M | $43.1M | $194.6M | −62% |
| 2013 | $123.2M | $102.6M | $193.8M | −29% |
| 2012 | $173.4M | $115M | $215M | +52% |
| 2011 | $114.4M | $93.9M | $122.4M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Achieve Life Sciences' size, closest first, today.
| Company | Market cap |
|---|---|
| ACHVAchieve Life Sciences | $680.2M |
| NRCNRC Health | $536.6M |
| VCYTVeracyte | $3.9B |
| CDNACareDx | $4.5B |
| ICCCImmucell | $95.9M |
| BLLNBillionToOne | $5.2B |
| LNTHLantheus | $6.5B |
| Peer median | $4.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Achieve Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.